146 related articles for article (PubMed ID: 2168965)
1. The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression.
Andrew ME; Boyle DB; Whitfeld PL; Lockett LJ; Anthony ID; Bellamy AR; Both GW
J Virol; 1990 Oct; 64(10):4776-83. PubMed ID: 2168965
[TBL] [Abstract][Full Text] [Related]
2. Relocation of antigens to the cell surface membrane can enhance immune stimulation and protection.
Both GW; Andrew ME; Boyle DB; Coupar BE; Bellamy AR
Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():73-8. PubMed ID: 1322362
[TBL] [Abstract][Full Text] [Related]
3. Presentation of neutralizing epitopes by engineered rotavirus VP7's expressed by recombinant vaccinia viruses.
Dormitzer PR; Both GW; Greenberg HB
Virology; 1994 Oct; 204(1):391-402. PubMed ID: 7522373
[TBL] [Abstract][Full Text] [Related]
4. Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.
Gorziglia M; Larralde G; Kapikian AZ; Chanock RM
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7155-9. PubMed ID: 1698292
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the newly identified neutralization epitopes on VP7 of human rotavirus serotype 1.
Kobayashi N; Taniguchi K; Urasawa S
J Gen Virol; 1991 Jan; 72 ( Pt 1)():117-24. PubMed ID: 1703558
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins.
Dormitzer PR; Ho DY; Mackow ER; Mocarski ES; Greenberg HB
Virology; 1992 Mar; 187(1):18-32. PubMed ID: 1371025
[TBL] [Abstract][Full Text] [Related]
7. Retention by the endoplasmic reticulum of rotavirus VP7 is controlled by three adjacent amino-terminal residues.
Maass DR; Atkinson PH
J Virol; 1994 Jan; 68(1):366-78. PubMed ID: 8254749
[TBL] [Abstract][Full Text] [Related]
8. An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide.
Franco MA; Prieto I; Labbé M; Poncet D; Borras-Cuesta F; Cohen J
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2579-86. PubMed ID: 8277264
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodies.
Andrew ME; Boyle DB; Coupar BE; Whitfeld PL; Both GW; Bellamy AR
J Virol; 1987 Apr; 61(4):1054-60. PubMed ID: 3029399
[TBL] [Abstract][Full Text] [Related]
10. Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus.
Mackow ER; Shaw RD; Matsui SM; Vo PT; Benfield DA; Greenberg HB
Virology; 1988 Aug; 165(2):511-7. PubMed ID: 2457279
[TBL] [Abstract][Full Text] [Related]
11. Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7.
Lazdins I; Coulson BS; Kirkwood C; Dyall-Smith M; Masendycz PJ; Sonza S; Holmes IH
Virology; 1995 May; 209(1):80-9. PubMed ID: 7747487
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus VP7 neutralization epitopes of serotype 3 strains.
Nishikawa K; Hoshino Y; Taniguchi K; Green KY; Greenberg HB; Kapikian AZ; Chanock RM; Gorziglia M
Virology; 1989 Aug; 171(2):503-15. PubMed ID: 2474892
[TBL] [Abstract][Full Text] [Related]
13. Expression of the gene coding for the major outer capsid protein of SA-11 rotavirus in a baculovirus system.
McGonigal TP; Turon MC; Komar-Hartnett K; Kister SE; Smith RE
Virus Res; 1992 Apr; 23(1-2):135-50. PubMed ID: 1318623
[TBL] [Abstract][Full Text] [Related]
14. Rotavirus-specific cytotoxic T lymphocytes recognize overlapping epitopes in the amino-terminal region of the VP7 glycoprotein.
Buesa J; Raga JV; Colomina J; de Souza CO; Muñoz C; Gil MT
Virology; 1999 May; 257(2):424-37. PubMed ID: 10329553
[TBL] [Abstract][Full Text] [Related]
15. Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutions.
Dunn SJ; Ward RL; McNeal MM; Cross TL; Greenberg HB
Virology; 1993 Nov; 197(1):397-404. PubMed ID: 7692670
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.
Kobayashi N; Taniguchi K; Urasawa T; Urasawa S
Arch Virol; 1991; 121(1-4):153-62. PubMed ID: 1722090
[TBL] [Abstract][Full Text] [Related]
17. Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus.
Fiore L; Dunn SJ; Ridolfi B; Ruggeri FM; Mackow ER; Greenberg HB
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1981-8. PubMed ID: 7636478
[TBL] [Abstract][Full Text] [Related]
18. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
19. Primary sequence domains required for the retention of rotavirus VP7 in the endoplasmic reticulum.
Poruchynsky MS; Atkinson PH
J Cell Biol; 1988 Nov; 107(5):1697-706. PubMed ID: 2846584
[TBL] [Abstract][Full Text] [Related]
20. Two forms of VP7 are involved in assembly of SA11 rotavirus in endoplasmic reticulum.
Kabcenell AK; Poruchynsky MS; Bellamy AR; Greenberg HB; Atkinson PH
J Virol; 1988 Aug; 62(8):2929-41. PubMed ID: 2839712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
